These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32426918)

  • 1. Abolishing spontaneous epileptiform activity in human brain tissue through AMPA receptor inhibition.
    Wright SK; Wilson MA; Walsh R; Lo WB; Mundil N; Agrawal S; Philip S; Seri S; Greenhill SD; Woodhall GL
    Ann Clin Transl Neurol; 2020 Jun; 7(6):883-890. PubMed ID: 32426918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perampanel and decanoic acid show synergistic action against AMPA receptors and seizures.
    Augustin K; Williams S; Cunningham M; Devlin AM; Friedrich M; Jayasekera A; Hussain MA; Holliman D; Mitchell P; Jenkins A; Chen PE; Walker MC; Williams RSB
    Epilepsia; 2018 Nov; 59(11):e172-e178. PubMed ID: 30324610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models.
    Zwart R; Sher E; Ping X; Jin X; Sims JR; Chappell AS; Gleason SD; Hahn PJ; Gardinier K; Gernert DL; Hobbs J; Smith JL; Valli SN; Witkin JM
    J Pharmacol Exp Ther; 2014 Oct; 351(1):124-33. PubMed ID: 25027316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AMPA receptor antagonist perampanel suppresses epileptic activity in human focal cortical dysplasia.
    Brito da Silva A; Pennifold J; Henley B; Chatterjee K; Bateman D; Whittaker RW; Joshi A; Kumar H; Nicholson C; Baker MR; Greenhill SD; Walsh R; Seri S; Jones RSG; Woodhall GL; Cunningham MO
    Epilepsia Open; 2022 Sep; 7(3):488-495. PubMed ID: 34653311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizure control by decanoic acid through direct AMPA receptor inhibition.
    Chang P; Augustin K; Boddum K; Williams S; Sun M; Terschak JA; Hardege JD; Chen PE; Walker MC; Williams RS
    Brain; 2016 Feb; 139(Pt 2):431-43. PubMed ID: 26608744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPA receptors as a molecular target in epilepsy therapy.
    Rogawski MA
    Acta Neurol Scand Suppl; 2013; (197):9-18. PubMed ID: 23480151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
    Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
    Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives.
    Di Bonaventura C; Labate A; Maschio M; Meletti S; Russo E
    Expert Opin Pharmacother; 2017 Nov; 18(16):1751-1764. PubMed ID: 29023170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.
    Lange F; Weßlau K; Porath K; Hörnschemeyer MF; Bergner C; Krause BJ; Mullins CS; Linnebacher M; Köhling R; Kirschstein T
    PLoS One; 2019; 14(2):e0211644. PubMed ID: 30716120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular insights into the role of AMPA receptors in the synaptic plasticity, pathogenesis and treatment of epilepsy: therapeutic potentials of perampanel and antisense oligonucleotide (ASO) technology.
    Charsouei S; Jabalameli MR; Karimi-Moghadam A
    Acta Neurol Belg; 2020 Jun; 120(3):531-544. PubMed ID: 32152997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perampanel: Does it have broad-spectrum potential?
    Potschka H; Trinka E
    Epilepsia; 2019 Mar; 60 Suppl 1():22-36. PubMed ID: 29953584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New AMPA antagonists in epilepsy.
    Russo E; Gitto R; Citraro R; Chimirri A; De Sarro G
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1371-89. PubMed ID: 22788917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of perampanel in young children with drug-resistant epilepsy.
    Chang FM; Fan PC; Weng WC; Chang CH; Lee WT
    Seizure; 2020 Feb; 75():82-86. PubMed ID: 31901668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN Is Required for The Anti-Epileptic Effects of AMPA Receptor Antagonists in Chronic Epileptic Rats.
    Kim JE; Park H; Lee JE; Kim TH; Kang TC
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery and development of perampanel for the treatment of epilepsy.
    Hanada T
    Expert Opin Drug Discov; 2014 Apr; 9(4):449-58. PubMed ID: 24559052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPA receptor antagonists as potential anticonvulsant drugs.
    De Sarro G; Gitto R; Russo E; Ibbadu GF; Barreca ML; De Luca L; Chimirri A
    Curr Top Med Chem; 2005; 5(1):31-42. PubMed ID: 15638776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel.
    Zaccara G; Giovannelli F; Cincotta M; Iudice A
    Expert Rev Neurother; 2013 Jun; 13(6):647-55. PubMed ID: 23739002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction: Perampanel--new mode of action and new option for patients with epilepsy.
    Steinhoff BJ
    Epilepsia; 2014 Jan; 55 Suppl 1():1-2. PubMed ID: 24400689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism.
    Kato AS; Burris KD; Gardinier KM; Gernert DL; Porter WJ; Reel J; Ding C; Tu Y; Schober DA; Lee MR; Heinz BA; Fitch TE; Gleason SD; Catlow JT; Yu H; Fitzjohn SM; Pasqui F; Wang H; Qian Y; Sher E; Zwart R; Wafford KA; Rasmussen K; Ornstein PL; Isaac JT; Nisenbaum ES; Bredt DS; Witkin JM
    Nat Med; 2016 Dec; 22(12):1496-1501. PubMed ID: 27820603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit.
    Rohracher A; Höfler J; Kalss G; Leitinger M; Kuchukhidze G; Deak I; Dobesberger J; Novak H; Pilz G; Zerbs A; Trinka E
    Epilepsy Behav; 2015 Aug; 49():354-8. PubMed ID: 25962657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.